113例新型冠状病毒肺炎死亡患者的临床特征:回顾性研究
该回顾性病例系列分析武汉同济医院799例COVID-19患者中113例死亡患者与161例康复患者的临床特征。死亡患者中位年龄68岁,显著高于康复患者的51岁;男性占73%,高血压占48%。死亡患者从发病到死亡中位时间16天,白细胞增多50%、淋巴细胞减少91%,转氨酶、肌酐、肌酸激酶、乳酸脱氢酶、肌钙蛋白I、NT-proBNP和D-二聚体均显著高于康复患者。死亡患者常见并发症包括急性呼吸窘迫综合征(100%)、脓毒症(100%)、急性心脏损伤(77%)、心力衰竭(49%)、急性肾损伤(25%)等。
要点
- 死亡患者中位年龄68岁、男性73%、合并高血压48%,均显著高于康复患者(51岁、55%、24%)。
- 死亡患者从发病到死亡中位时间16天(四分位距12.0-20.0天)。
- 死亡患者淋巴细胞减少91%、白细胞增多50%,康复患者分别为47%和4%。
- 死亡患者常见并发症:急性呼吸窘迫综合征100%、脓毒症100%、急性心脏损伤77%、心力衰竭49%、急性肾损伤25%。
- 有心血管合并症者更易发生心脏并发症;无论有无心血管病史,死亡患者急性心脏损伤和心力衰竭均更常见。
适用人群与场景
- 武汉同济医院799例COVID-19患者中的113例死亡患者和161例康复患者,数据收集至2020年2月28日。
红旗征与不能漏的情况
- 呼吸困难、胸闷、意识障碍在死亡患者中更常见(分别为62%、49%、22%),康复患者分别为31%、30%、1%。
- 死亡患者常见急性呼吸窘迫综合征(100%)、脓毒症(100%)、急性心脏损伤(77%)、心力衰竭(49%)、急性肾损伤(25%)、缺氧性脑病(20%)。
研究设计与关键结果
- 回顾性病例系列,纳入799例COVID-19患者中的113例死亡患者和161例康复患者,比较临床特征和实验室检查。
- 死亡患者中位年龄68岁 vs 康复患者51岁;男性83例(73%) vs 88例(55%);慢性高血压54例(48%) vs 39例(24%);其他心血管合并症16例(14%) vs 7例(4%)。
- 死亡患者呼吸困难70例(62%) vs 康复患者50例(31%);胸闷55例(49%) vs 48例(30%);意识障碍25例(22%) vs 1例(1%)。
- 死亡患者从发病到死亡中位时间16天(四分位距12.0-20.0天)。
- 死亡患者白细胞增多56例(50%) vs 康复患者6例(4%);淋巴细胞减少103例(91%) vs 76例(47%)。
- 死亡患者丙氨酸氨基转移酶、天冬氨酸氨基转移酶、肌酐、肌酸激酶、乳酸脱氢酶、心肌肌钙蛋白I、N末端脑钠肽前体和D-二聚体浓度均显著高于康复患者。
- 死亡患者并发症:急性呼吸窘迫综合征113例(100%)、I型呼吸衰竭18/35例(51%)、脓毒症113例(100%)、急性心脏损伤72/94例(77%)、心力衰竭41/83例(49%)、碱中毒14/35例(40%)、高钾血症42例(37%)、急性肾损伤28例(25%)、缺氧性脑病23例(20%)。
- 有心血管合并症的患者更易发生心脏并发症;无论有无心血管病史,死亡患者急性心脏损伤和心力衰竭均更常见。
证据类型、等级与局限
- 回顾性病例系列;局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,SARS-CoV-2感染可导致肺部及全身炎症,高危患者出现多器官功能障碍;急性呼吸窘迫综合征和呼吸衰竭、脓毒症、急性心脏损伤和心力衰竭是COVID-19恶化期最常见的危重并发症。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To delineate the clinical characteristics of patients with coronavirus disease 2019 (covid-19) who died.
DESIGN: Retrospective case series.
SETTING: Tongji Hospital in Wuhan, China.
PARTICIPANTS: Among a cohort of 799 patients, 113 who died and 161 who recovered with a diagnosis of covid-19 were analysed. Data were collected until 28 February 2020.
MAIN OUTCOME MEASURES: Clinical characteristics and laboratory findings were obtained from electronic medical records with data collection forms.
RESULTS: The median age of deceased patients (68 years) was significantly older than recovered patients (51 years). Male sex was more predominant in deceased patients (83; 73%) than in recovered patients (88; 55%). Chronic hypertension and other cardiovascular comorbidities were more frequent among deceased patients (54 (48%) and 16 (14%)) than recovered patients (39 (24%) and 7 (4%)). Dyspnoea, chest tightness, and disorder of consciousness were more common in deceased patients (70 (62%), 55 (49%), and 25 (22%)) than in recovered patients (50 (31%), 48 (30%), and 1 (1%)). The median time from disease onset to death in deceased patients was 16 (interquartile range 12.0-20.0) days. Leukocytosis was present in 56 (50%) patients who died and 6 (4%) who recovered, and lymphopenia was present in 103 (91%) and 76 (47%) respectively. Concentrations of alanine aminotransferase, aspartate aminotransferase, creatinine, creatine kinase, lactate dehydrogenase, cardiac troponin I, N-terminal pro-brain natriuretic peptide, and D-dimer were markedly higher in deceased patients than in recovered patients. Common complications observed more frequently in deceased patients included acute respiratory distress syndrome (113; 100%), type I respiratory failure (18/35; 51%), sepsis (113; 100%), acute cardiac injury (72/94; 77%), heart failure (41/83; 49%), alkalosis (14/35; 40%), hyperkalaemia (42; 37%), acute kidney injury (28; 25%), and hypoxic encephalopathy (23; 20%). Patients with cardiovascular comorbidity were more likely to develop cardiac complications. Regardless of history of cardiovascular disease, acute cardiac injury and heart failure were more common in deceased patients.
CONCLUSION: Severe acute respiratory syndrome coronavirus 2 infection can cause both pulmonary and systemic inflammation, leading to multi-organ dysfunction in patients at high risk. Acute respiratory distress syndrome and respiratory failure, sepsis, acute cardiac injury, and heart failure were the most common critical complications during exacerbation of covid-19.
参考来源
- Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020. PMID: 32217556. doi:10.1136/bmj.m1091
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。